Insufficient scRNA-seq data for expression of FETUB at single-cell level.
Insufficient scRNA-seq data for expression of FETUB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 3763.11 | 226 / 226 | 90% | 91.06 | 364 / 406 |
| skin | 70% | 159.12 | 1271 / 1809 | 4% | 0.16 | 20 / 472 |
| esophagus | 32% | 98.95 | 458 / 1445 | 30% | 6.23 | 54 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 4.50 | 21 / 45 |
| lung | 0% | 0 | 0 / 578 | 20% | 5.61 | 236 / 1155 |
| kidney | 10% | 6.21 | 9 / 89 | 3% | 0.15 | 30 / 901 |
| uterus | 1% | 3.99 | 2 / 170 | 10% | 2.26 | 48 / 459 |
| brain | 2% | 0.91 | 63 / 2642 | 5% | 0.09 | 34 / 705 |
| blood vessel | 6% | 2.85 | 80 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 3% | 2.21 | 10 / 328 | 1% | 0.03 | 2 / 178 |
| peripheral blood | 3% | 2.73 | 28 / 929 | 0% | 0 | 0 / 0 |
| breast | 1% | 0.57 | 6 / 459 | 2% | 0.03 | 19 / 1118 |
| intestine | 0% | 0.08 | 2 / 966 | 2% | 0.17 | 12 / 527 |
| bladder | 0% | 0 | 0 / 21 | 2% | 0.19 | 10 / 504 |
| ovary | 1% | 0.17 | 1 / 180 | 1% | 0.03 | 5 / 430 |
| stomach | 0% | 0.15 | 1 / 359 | 1% | 0.02 | 4 / 286 |
| thymus | 0% | 0.04 | 1 / 653 | 1% | 0.01 | 5 / 605 |
| heart | 1% | 0.35 | 8 / 861 | 0% | 0 | 0 / 0 |
| adipose | 1% | 0.29 | 7 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0.51 | 1 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0.12 | 1 / 258 | 0% | 0 | 0 / 230 |
| muscle | 0% | 0.12 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007339 | Biological process | binding of sperm to zona pellucida |
| GO_0010951 | Biological process | negative regulation of endopeptidase activity |
| GO_0007338 | Biological process | single fertilization |
| GO_0008150 | Biological process | biological_process |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008191 | Molecular function | metalloendopeptidase inhibitor activity |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | FETUB |
| Protein name | Fetuin-B (16G2) (Fetuin-like protein IRL685) (Gugu) Fetuin B |
| Synonyms | |
| Description | FUNCTION: Protease inhibitor required for egg fertilization. Required to prevent premature zona pellucida hardening before fertilization, probably by inhibiting the protease activity of ASTL, a protease that mediates the cleavage of ZP2 and triggers zona pellucida hardening (By similarity). . |
| Accessions | ENST00000435961.5 C9JC68 ENST00000431018.5 ENST00000265029.8 [Q9UGM5-1] ENST00000382134.7 ENST00000382136.3 [Q9UGM5-2] ENST00000420570.1 F8WAW1 E9PG08 F8WEP7 Q9UGM5 ENST00000450521.5 [Q9UGM5-1] |